JAN M. AGOSTI, M.D.; KIRK D. MILLER, M.D.; MARGUERITE PAPPAIOANOU, D.V.M., Ph.D.; ELAINE C. JONG, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Because of its rapid activity, quinine dihydrochloride is the drug of choice for the intitial treatment of severe Plasmodium falciparum infections. In the United States this drug must be obtained from the Centers for Disease Control, resulting in delays of up to 12 hours in starting therapy. Prompt therapy of P. falciparum infections is essential in reducing the risk of death. Indeed, a study of cerebral malaria in Thailand has shown that patients who died received quinine later in their illness than those who survived (1). We report the case of a patient with cerebral malaria treated
AGOSTI JM, MILLER KD, PAPPAIOANOU M, et al. Plasmodium falciparum Malaria and Intravenous Quinidine Gluconate. Ann Intern Med. 1985;103:307. doi: https://doi.org/10.7326/0003-4819-103-2-307_1
Download citation file:
Published: Ann Intern Med. 1985;103(2):307.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use